Fogel Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.35M Buy
38,263
+1,381
+4% +$322K 4.28% 9
2025
Q4
$7.63M Buy
36,882
+205
+0.6% +$40.5K 3.52% 8
2025
Q3
$6.8M Sell
36,677
-103
-0.3% -$17.6K 3.15% 10
2025
Q2
$5.62M Sell
36,780
-600
-2% -$92.2K 3% 10
2025
Q1
$6.2M Sell
37,380
-1,297
-3% -$203K 3.33% 9
2024
Q4
$5.59M Buy
38,677
+588
+2% +$91.1K 2.81% 10
2024
Q3
$6.17M Sell
38,089
-720
-2% -$115K 3.18% 11
2024
Q2
$5.67M Sell
38,809
-93
-0.2% -$13.8K 3.02% 11
2024
Q1
$5.81M Sell
38,902
-552
-1% -$87.9K 3.41% 10
2023
Q4
$6.17M Buy
+39,454
New +$6.05M 4.71% 6

Other funds holding JNJ

Fogel Capital Management's JNJ Position: Q1 2026 in Review

Fogel Capital Management increased its Johnson & Johnson (JNJ) stake by 3.7% in Q1 2026, buying an estimated $322K and bringing the position to 38,263 shares worth $9.35M. The position accounts for 4.28% of the portfolio, ranked #9.

Fogel Capital Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fogel Capital Management held 38,263 shares of Johnson & Johnson worth $9.35M as of Q1 2026.
  • Fogel Capital Management bought 1,381 Johnson & Johnson shares in Q1 2026, an estimated $322K.
  • Johnson & Johnson made up 4.28% of Fogel Capital Management's portfolio in Q1 2026, its #9 holding.
  • Fogel Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fogel Capital Management's 13F filing for Q1 2026, filed 13 May 2026.